Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	20.75	44.58	69.72	66.84	51.21	24.87	7.39
Short-Term Investments	54.31	45.6	37.08	66.98	48.65	46.84	0
Cash & Cash Equivalents	75.06	90.18	106.8	133.82	99.86	71.72	7.39
Cash Growth	-16.77%	-15.56%	-20.19%	34.00%	39.25%	870.05%	-
Other Current Assets	2.38	3.57	4.87	4.04	6.19	0.87	0.14
Total Current Assets	77.44	93.75	111.67	137.86	106.06	72.58	7.54
Property, Plant & Equipment	0.62	0.68	1.43	1.1	1.33	0.28	0.12
Long-Term Investments	0.08	3.58	19.93	50.46	16.76	0	0
Goodwill and Intangibles	81.3	5.9	0	0	0	0	0
Other Long-Term Assets	8.47	0	0.19	0.04	0.22	0.01	0.06
Total Long-Term Assets	90.46	10.16	21.56	51.6	18.31	0.29	0.18
Total Assets	167.9	103.91	133.23	189.47	124.37	72.88	7.72
Accounts Payable	2.03	0.57	4.91	3.56	3.08	0.5	0.52
Other Current Liabilities	7.54	2.5	9.31	13.44	5.82	0.96	1.25
Total Current Liabilities	9.57	3.07	14.22	17	8.89	1.46	1.76
Long-Term Debt	13.75	0	0.42	0.21	0	0	7.17
Other Long-Term Liabilities	59.49	0.25	0	0	0	0	1.89
Total Long-Term Liabilities	73.24	0.25	0.42	0.21	0	0	9.06
Total Liabilities	82.82	3.32	14.64	17.2	8.89	1.46	10.82
Total Debt	13.75	0	0.42	0.21	0	0	7.17
Debt Growth	-	-	101.92%	-	-	-	-
Retained Earnings	-319.64	-288.26	-236.6	-146.65	-69.81	-32.83	-20.35
Comprehensive Income	3.05	-0.29	-0.08	0.31	0.06	-0.05	0
Shareholders' Equity	85.08	100.59	118.59	172.26	115.48	-32.63	-20.28
Net Cash / Debt	61.31	90.18	106.38	133.61	99.86	71.72	0.22
Net Cash / Debt Growth	-32.02%	-15.23%	-20.38%	33.79%	39.25%	32204.50%	-
Net Cash Per Share	1.65	2.69	3.58	4.58	5.25	21.33	0.07
Working Capital	67.87	90.68	97.45	120.87	97.16	71.13	5.77
Book Value Per Share	2.29	3.00	3.99	5.90	6.07	-9.70	-6.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).